Literature DB >> 11893929

Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.

Hiroyasu Yoshikawa1, Yuji Tajiri, Yasuhiro Sako, Toshihiko Hashimato, Fumio Umeda, Hajime Nawata.   

Abstract

INTRODUCTION: The mechanism for beta-cell dysfunction induced by glucosamine has not yet fully been investigated previously. AIM: To investigate the effects of glucosamine on insulin release or gene expression related to glucose metabolism in rat islets cultured with glucosamine for 24 hours.
METHODOLOGY: After islets were cultured with glucosamine or diazoxide, we measured glucose- or arginine-induced insulin release by using radioimmunoassay (RIA) and gene expressions by semiquantitative polymerase/chain reaction.
RESULTS: Coculture with glucosamine inhibited 27 mmol/L glucose-induced insulin release with no effects on 20 mmol/L arginine-induced insulin release. Coculture with diazoxide did not restore the impaired glucose-induced insulin release. In glucosamine-cultured islets, glucose-transporter type 2 or glucokinase mRNA expression decreased, whereas hexokinase mRNA increased. Phosphofructokinase-A, pyruvate dehydrogenase E1alpha, or pyruvate carboxylase mRNA was not affected by the addition of glucosamine. Pancreatic and duodenal homeobox-1, preproinsulin, or p21 (induced by oxidative stress) mRNA expression did not change, whereas uncoupling protein 2 mRNA, which plays an important role in thermogenesis, decreased in glucosamine-cultured islets.
CONCLUSION: These data imply that glucosamine impairs glucose-induced insulin release probably through the inhibition of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893929     DOI: 10.1097/00006676-200204000-00004

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Hexosamine biosynthetic pathway activity in leptin resistant sucrose-drinking rats.

Authors:  Ruth B S Harris; John W Apolzan
Journal:  Physiol Behav       Date:  2014-11-06

Review 2.  Natural history of β-cell adaptation and failure in type 2 diabetes.

Authors:  Emilyn U Alejandro; Brigid Gregg; Manuel Blandino-Rosano; Corentin Cras-Méneur; Ernesto Bernal-Mizrachi
Journal:  Mol Aspects Med       Date:  2014-12-24

3.  The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.

Authors:  Yong Zhang; Yuping Zhang; Kun Sun; Ziyi Meng; Ligong Chen
Journal:  J Mol Cell Biol       Date:  2019-01-01       Impact factor: 6.216

4.  Brain-derived neurotrophic factor in VMH as the causal factor for and therapeutic tool to treat visceral adiposity and hyperleptinemia in type 2 diabetic Goto-Kakizaki rats.

Authors:  Fumihiko Maekawa; Ken Fujiwara; Masako Toriya; Yuko Maejima; Takashi Nishio; Yukiyasu Toyoda; Keiko Nohara; Takashi Yashiro; Toshihiko Yada
Journal:  Front Synaptic Neurosci       Date:  2013-10-02

5.  Hexosamine pathway but not interstitial changes mediates glucotoxicity in pancreatic β-cells as assessed by cytosolic Ca2+ response to glucose.

Authors:  Kazuhiro Yanagida; Yuko Maejima; Putra Santoso; Zesemdorj Otgon-Uul; Yifei Yang; Kazuya Sakuma; Kenju Shimomura; Toshihiko Yada
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

6.  Short-term glucosamine infusion increases islet blood flow in anesthetized rats.

Authors:  Xiang Gao; Leif Jansson; A Erik G Persson; Monica Sandberg
Journal:  Islets       Date:  2013-11-25       Impact factor: 2.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.